PECAM-independent thioglycollate peritonitis is associated with a locus on murine chromosome 2

PLoS ONE

Volumn 4, Issue 1, 2009, Pages

  Seidman, Michael A ^a   Chew, Tina W ^a   Schenkel, Alan R ^b   Muller, William A ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; COMPLEMENT COMPONENT C5; THIOGLYCOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; GENE IDENTIFICATION; GENE LOCUS; GENETIC TRAIT; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; PERITONITIS; PHENOTYPE; QUANTITATIVE TRAIT LOCUS MAPPING;

ANIMALS; ANTIGENS, CD31; CHROMOSOME MAPPING; CHROMOSOMES, MAMMALIAN; DISEASE MODELS, ANIMAL; INFLAMMATION; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONITIS; QUANTITATIVE TRAIT LOCI; THIOGLYCOLATES;

MURINAE; MUS;

EID: 74749104066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004316     Document Type: Article

References (46)

1. Muller WA (2002) Leukocyte-endothelial cell interactions in the inflammatory response. Laboratory Investigation 82: 521-534.
2. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature Reviews Immunology 7: 678-689.
3. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, et al. (1999) Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 162: 3022-3030.
4. Wong MX, Roberts D, Bartley PA, Jackson DE (2002) Absence of platelet endothelial cell adhesion molecule-1 (CD31) leads to increased severity of local and systemic IgE-mediated anaphylaxis and modulation of mast cell activation. J Immunol 168: 6455-6462.
5. Wilkinson R, Lyons AB, Roberts D, Wong MX, Bartley PA, et al. (2002) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100: 184-193.
6. Thompson RD, Noble KE, Larbi KY, Dewar A, Duncan GS, et al. (2001) Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 97: 1854-1860.
7. Solowiej A, Biswas P, Graesser D, Madri JA (2003) Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 162: 953-962.
8. Mahooti S, Graesser D, Patil S, Newman P, Duncan G, et al. (2000) PECAM-1 (CD31) expression modulates bleeding time in vivo. Am J Pathol 157: 75-81.
9. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, et al. (2002) Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109: 383-392.
10. Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, et al. (2003) PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 102: 169-179.
11. Patil S, Newman DK, Newman PJ (2001) Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 97: 1727-1732.
12. Biswas P, Canosa S, Schoenfeld J, Schoenfeld D, Tucker A, et al. (2003) PECAM-1 promotes beta-catenin accumulation and stimulates endothelial cell proliferation. Biochem Biophys Res Commun 303: 212-218.
13. Dangerfield J, Larbi KY, Huang MT, Dewar A, Nourshargh S (2002) PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of a6b1 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med 196: 1201-1211.
14. Liao F, Schenkel AR, Muller WA (1999) Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J Immunol 163: 5640-5648.
15. Schenkel AR, Chew TW, Muller WA (2004) Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J Immunol 173: 6403-6408.
16. Flint J, Valdar W, Shifman S, Mott R (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6: 271-286.
17. Teupser D, Tan M, Persky AD, Breslow JL (2006) Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/ N low-density lipoprotein receptor2/2 mice. Proc Natl Acad Sci U S A 103: 123-128.
18. Fan JB, Chee MS, Gunderson KL (2006) Highly parallel genomic assays. Nat Rev Genet 7: 632-644.
19. Liao F, Ali J, Greene T, Muller WA (1997) Soluble domain 1 of plateletendothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 185: 1349-1357.
20. Bogen SA, Baldwin HS, Watkins SC, Albelda SM, Abbas AK (1992) Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol 141: 843-854.
21. Bogen S, Pak J, Garifallou M, Deng X, Muller WA (1994) Monoclonal antibody to murine PECAM-1 [CD31] blocks acute inflammation in vivo. J Exp Med 179: 1059-1064.
22. Broman KW, Wu H, Sen S, Churchill GA (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
23. Welkos SL, Keener TJ, Gibbs PH (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51: 795-800.
24. Welkos SL, Friedlander AM (1988) Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog 4: 53-69.
25. Brownstein DG, Bhatt PN, Gras L, Jacoby RO (1991) Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J Virol 65: 1946-1951.
26. McIndoe RA, Bohlman B, Chi E, Schuster E, Lindhardt M, et al. (1999) Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci U S A 96: 2210-2214.
27. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, et al. (2001) Genetic influences on the end-stage effector phase of arthritis. J Exp Med 194: 321-330.
28. Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, et al. (2004) Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum 50: 3721-3728.
29. Ewart SL, Kuperman D, Schadt E, Tankersley C, Grupe A, et al. (2000) Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 23: 537-545.
30. Karp CL, Grupe A, Schadt E, Ewart SL, Keane-Moore M, et al. (2000) Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 1: 221-226.
31. Cinader B, Dubiski S, Wardlaw AC (1964) Distribution, Inheritance, and Properties of an Antigen, Mub1, and Its Relation to Hemolytic Complement. J Exp Med 120: 897-924.
32. Nilsson UR, Muller-Eberhard HJ (1967) Deficiency of the fifth component of complement in mice with an inherited complement defect. J Exp Med 125: 1-16.
33. Wetsel RA, Fleischer DT, Haviland DL (1990) Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 59-exon. J Biol Chem 265: 2435-2440.
34. Haviland DL, Haviland JC, Fleischer DT, Wetsel RA (1991) Structure of the murine fifth complement component (C5) gene. A large, highly interrupted gene with a variant donor splice site and organizational homology with the third and fourth complement component genes. J Biol Chem 266: 11818-11825.
35. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, et al. (2000) A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 164: 4340-4347.
36. Tilley SL, Coffman TM, Koller BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108: 15-23.
37. Serhan CN, Oliw E (2001) Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107: 1481-1489.
38. Narumiya S, FitzGerald GA (2001) Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 108: 25-30.
39. Trebino CE, Eskra JD, Wachtmann TS, Perez JR, Carty TJ, et al. (2005) Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J Biol Chem 280: 16579-16585.
40. Simmons DL, Botting RM, Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437.
41. Rocca B, FitzGerald GA (2002) Cyclooxygenases and prostaglandins: shaping up the immune response. Int Immunopharmacol 2: 603-630.
42. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
43. Langenbach R, Loftin CD, Lee C, Tiano H (1999) Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann N Y Acad Sci 889: 52-61.
44. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A 100: 9044-9049.
45. Wade CM, Kulbokas EJ 3rd, Kirby AW, Zody MC, Mullikin JC, et al. (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578.
46. Muller WA (2007) PECAM: Regulating the Start of Diapedesis. In: Ley K, ed. Adhesion Molecules: Function and Inhibition. Basel, Switzerland: Birkhauser Verlag AG.